1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety Biomarker
1.2.3 Validation Biomarker
1.2.4 Efficacy Biomarker
1.3 Market by Application
1.3.1 Global Digital Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sleep and Movement
1.3.3 Cardiovascular
1.3.4 Mood and Behavior
1.3.5 Pain Management
1.3.6 Respiratory Conditions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Digital Biomarker Market Perspective (2016-2027)
2.2 Digital Biomarker Growth Trends by Regions
2.2.1 Digital Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Digital Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Digital Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Digital Biomarker Industry Dynamic
2.3.1 Digital Biomarker Market Trends
2.3.2 Digital Biomarker Market Drivers
2.3.3 Digital Biomarker Market Challenges
2.3.4 Digital Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Biomarker Players by Revenue
3.1.1 Global Top Digital Biomarker Players by Revenue (2016-2021)
3.1.2 Global Digital Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Digital Biomarker Revenue
3.4 Global Digital Biomarker Market Concentration Ratio
3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2020
3.5 Digital Biomarker Key Players Head office and Area Served
3.6 Key Players Digital Biomarker Product Solution and Service
3.7 Date of Enter into Digital Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Biomarker Breakdown Data by Type
4.1 Global Digital Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Digital Biomarker Forecasted Market Size by Type (2022-2027)
5 Digital Biomarker Breakdown Data by Application
5.1 Global Digital Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Digital Biomarker Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Digital Biomarker Market Size (2016-2027)
6.2 North America Digital Biomarker Market Size by Type
6.2.1 North America Digital Biomarker Market Size by Type (2016-2021)
6.2.2 North America Digital Biomarker Market Size by Type (2022-2027)
6.2.3 North America Digital Biomarker Market Size by Type (2016-2027)
6.3 North America Digital Biomarker Market Size by Application
6.3.1 North America Digital Biomarker Market Size by Application (2016-2021)
6.3.2 North America Digital Biomarker Market Size by Application (2022-2027)
6.3.3 North America Digital Biomarker Market Size by Application (2016-2027)
6.4 North America Digital Biomarker Market Size by Country
6.4.1 North America Digital Biomarker Market Size by Country (2016-2021)
6.4.2 North America Digital Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Digital Biomarker Market Size (2016-2027)
7.2 Europe Digital Biomarker Market Size by Type
7.2.1 Europe Digital Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Digital Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Digital Biomarker Market Size by Type (2016-2027)
7.3 Europe Digital Biomarker Market Size by Application
7.3.1 Europe Digital Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Digital Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Digital Biomarker Market Size by Application (2016-2027)
7.4 Europe Digital Biomarker Market Size by Country
7.4.1 Europe Digital Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Digital Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Digital Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Digital Biomarker Market Size by Type
8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Digital Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Digital Biomarker Market Size by Application
8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Digital Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Digital Biomarker Market Size by Region
8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Digital Biomarker Market Size (2016-2027)
9.2 Latin America Digital Biomarker Market Size by Type
9.2.1 Latin America Digital Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Digital Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Digital Biomarker Market Size by Type (2016-2027)
9.3 Latin America Digital Biomarker Market Size by Application
9.3.1 Latin America Digital Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Digital Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Digital Biomarker Market Size by Application (2016-2027)
9.4 Latin America Digital Biomarker Market Size by Country
9.4.1 Latin America Digital Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Digital Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Digital Biomarker Market Size by Type
10.2.1 Middle East & Africa Digital Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Digital Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Digital Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Digital Biomarker Market Size by Application
10.3.1 Middle East & Africa Digital Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Digital Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Digital Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Digital Biomarker Market Size by Country
10.4.1 Middle East & Africa Digital Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Digital Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ActiGraph
11.1.1 ActiGraph Company Details
11.1.2 ActiGraph Business Overview
11.1.3 ActiGraph Digital Biomarker Introduction
11.1.4 ActiGraph Revenue in Digital Biomarker Business (2016-2021)
11.1.5 ActiGraph Recent Development
11.2 Akili Interactive Labs
11.2.1 Akili Interactive Labs Company Details
11.2.2 Akili Interactive Labs Business Overview
11.2.3 Akili Interactive Labs Digital Biomarker Introduction
11.2.4 Akili Interactive Labs Revenue in Digital Biomarker Business (2016-2021)
11.2.5 Akili Interactive Labs Recent Development
11.3 AliveCor
11.3.1 AliveCor Company Details
11.3.2 AliveCor Business Overview
11.3.3 AliveCor Digital Biomarker Introduction
11.3.4 AliveCor Revenue in Digital Biomarker Business (2016-2021)
11.3.5 AliveCor Recent Development
11.4 Fitbit
11.4.1 Fitbit Company Details
11.4.2 Fitbit Business Overview
11.4.3 Fitbit Digital Biomarker Introduction
11.4.4 Fitbit Revenue in Digital Biomarker Business (2016-2021)
11.4.5 Fitbit Recent Development
11.5 HumanAPI
11.5.1 HumanAPI Company Details
11.5.2 HumanAPI Business Overview
11.5.3 HumanAPI Digital Biomarker Introduction
11.5.4 HumanAPI Revenue in Digital Biomarker Business (2016-2021)
11.5.5 HumanAPI Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Digital Biomarker Introduction
11.6.4 Novartis Revenue in Digital Biomarker Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Digital Biomarker Introduction
11.7.4 Pfizer Revenue in Digital Biomarker Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Digital Biomarker Introduction
11.8.4 Roche Revenue in Digital Biomarker Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Digital Biomarker Introduction
11.9.4 Sanofi Revenue in Digital Biomarker Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Takeda Pharmaceuticals
11.10.1 Takeda Pharmaceuticals Company Details
11.10.2 Takeda Pharmaceuticals Business Overview
11.10.3 Takeda Pharmaceuticals Digital Biomarker Introduction
11.10.4 Takeda Pharmaceuticals Revenue in Digital Biomarker Business (2016-2021)
11.10.5 Takeda Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer